AGs Push High Court To Hear Pay-For-Delay Drug Suit
Attorneys general from 32 states urged the U.S. Supreme Court Friday to take up a case on the legality of so-called pay-for-delay agreements in which brand-name drug companies pay generics manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article